May 2016 Blog Posts (2)

Changing Strategies in the 'War on Cancer'

The National Cancer Act signed in 1971 officially started what is commonly referred to as the “war against cancer.” Since the signing of the bill, billions of dollars have been used towards “a total national commitment towards the conquest of cancer” with a stated goal of “finding a cure.” 

Government spending has been tremendously beneficial, providing funding for basic cancer research which is the foundation for new cancer treatments.As a result of ongoing…

Continue

Added by Editorial Team on May 27, 2016 at 6:30pm — No Comments

Genentech's Obinutuzumab Showed Superior Progression-Free Survival Compared to Rituximab in People with Previously Untreated Follicular Lymphoma

Positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin’s lymphoma (iNHL). The study compared the efficacy and safety of obinutuzumab (Gazyva®; Genentech) plus chemotherapy (CHOP, CVP or bendamustine) followed by obinutuzumab alone, head-to-head with rituximab (…

Continue

Added by Editorial Team on May 26, 2016 at 9:00pm — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+